Quanterix Corporation
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a QTRX research report →
Companywww.quanterix.com
Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. It offers HD-X instrument, a sensitive automated multiplex protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection technology in various applications, including direct detection of nucleic acids. The company also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays.
- CEO
- Everett V. Cunningham
- IPO
- 2017
- Employees
- 471
- HQ
- Billerica, MA, US
Price Chart
Valuation
- Market Cap
- $118.71M
- P/E
- -1.14
- P/S
- 0.82
- P/B
- 0.42
- EV/EBITDA
- -1.31
- Div Yield
- 0.00%
Profitability
- Gross Margin
- 44.13%
- Op Margin
- -82.71%
- Net Margin
- -71.92%
- ROE
- -35.17%
- ROIC
- -36.13%
Growth & Income
- Revenue
- $138.65M · 2.38%
- Net Income
- $-107,150,000 · -178.09%
- EPS
- $-2.51 · -151.00%
- Op Income
- $-109,815,000
- FCF YoY
- -107.23%
Performance & Tape
- 52W High
- $8.77
- 52W Low
- $2.40
- 50D MA
- $3.54
- 200D MA
- $5.33
- Beta
- 1.15
- Avg Volume
- 1.06M
Get TickerSpark's AI analysis on QTRX
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Recent Insider Transactions
| Date | Insider | Type | Shares |
|---|---|---|---|
| May 15, 26 | Sriram Vandana | other | 1,056 |
| May 15, 26 | Sriram Vandana | other | 1,056 |
| May 15, 26 | Sriram Vandana | other | 315 |
| May 15, 26 | Sriram Vandana | other | 514 |
| May 15, 26 | Sriram Vandana | other | 154 |
| May 15, 26 | Sriram Vandana | other | 263 |
| May 15, 26 | Sriram Vandana | other | 79 |
| May 15, 26 | Sriram Vandana | other | 514 |
| May 15, 26 | Sriram Vandana | other | 263 |
| May 15, 26 | Miller Michael Francis | other | 834 |
Our QTRX Coverage
We haven't published any research on QTRX yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate QTRX Report →